Lorenzo Volpicelli

6PUBLICATIONS
10CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 18, 2024
Impact of renal-adjusted ceftazidime/avibactam in patients with KPC-producing Klebsiella pneumoniae bloodstream infection: a retrospective cohort study.

A Oliva, L Volpicelli, A Gigante

|Jul 04, 2024
A role for ceftazidime/avibactam combination therapy: the question may still be on the table.

Lorenzo Volpicelli, Alessandra Oliva

|Dec 23, 2023
New Antimicrobials and New Therapy Strategies for Endocarditis: Weapons That Should Be Defended.

Alessandra Oliva, Francesco Cogliati Dezza, Francesca Cancelli

|Jun 10, 2023
Evaluation of the Factors Associated with Reinfections towards SARS-CoV-2 Using a Case Control Design.

Giuseppe La Torre, Gianluca Paglione, Lavinia Camilla Barone

|Feb 21, 2023
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin.

Lorenzo Volpicelli, Mario Venditti, Alessandra Oliva

|Mar 26, 2022
Risk of Seven-Day Worsening and Death: A New Clinically Derived COVID-19 Score.

Alessia Cruciata, Lorenzo Volpicelli, Silvia Di Bari

Pageof 1

Frequent Collaborators

4 joint publications

Alessandra Oliva

2 joint publications

Mario Venditti

1 joint publications

Gioacchino Galardo

1 joint publications

Giuseppe La Torre